Kaleida Health

04/24/2024 | Press release | Distributed by Public on 04/24/2024 13:37

BGMC/GVI Now Offering Symplicity Blood Pressure Procedure

Released: Wednesday, April 24, 2024 3:27 PM

BGMC/GVI Now Offering Symplicity Blood Pressure Procedure

As leaders in cardiovascular care, our integrated team of specialists at Buffalo General Medical Center/Gates Vascular Institute (BGMC/GVI) are continuously exploring the latest treatment options that support our patient-centered approach to care. Our focus on innovations in disease management is at the forefront of our daily work, and since high blood pressure is a prominent health concern for over 1 billion people worldwide, BGMC/GVI is excited to offer patients a new treatment option, which was recently approved by the U.S. Food and Drug Administration (FDA), to potentially manage their condition.

BGMC/GVI is now performing renal denervation (RDN) procedures for patients with high blood pressure, or hypertension. The RDN procedure - known as the Symplicity™ blood pressure procedure - is a minimally invasive technique that targets nerves near the kidneys that can become overactive and cause elevated blood pressure. After mild sedation, the doctor insets a very thin tube into the artery leading to the kidney. The doctor then administers energy to calm the excessive activity of the nerves connected to the kidney. The tube is removed, leaving no implant behind. The procedure is approved for use as an adjunctive treatment in patients with hypertension when lifestyle changes and medications do not adequately control blood pressure.

As we look to improve the way we treat patients with hypertension, Buffalo General Medical Center/Gates Vascular Insititute is interested in utilizing the latest technological innovations that meet the needs of patients and physicians. For people with hypertension, medication and/or lifestyle changes can help reduce blood pressure, but studies have shown that many people still don't have control over their condition. RDN could help fill that gap to potentially provide a blood pressure reduction benefit that is 'always on' and doesn't require a permanent implant.